COVID-19 Vaccines Do Not Increase Risk for Thyroid Diseases
COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.
Related Articles
Help Select Leaders
We are looking for a dynamic group of members familiar with the Society to join our Nominating Committee.
GLP-1 receptor agonists tied to similar thyroid cancer risk as DPP-IV inhibitors
Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according…
Rating the response of primary aldosteronism to targeted medical treatment with the PAMO criteria
The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these consequences are increased blood pressure and suppressed plasma…
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
The Primary Aldosteronism Medical Treatment Outcome (PAMO) criteria represent an internationally developed outcome standard that can guide clinical practice and research into primary aldosteronism. Efforts…
Thyroid Nodules: Past, Present, and Future
Over the past millennia, the evaluation and management of thyroid nodules has essentially remained the same with thyroidectomy as the only reliable method to identify…
2024 Innovation Challenge | American Diabetes Association
At the American Diabetes Association (ADA), we are dedicated to advancing care that will improve the lives of everyone affected by diabetes—until the day we…
On-Demand Education – The Obesity Society
On-Demand Education: Science from The Obesity Society The Obesity Society (TOS) on-demand education is a great way to gain an in-depth understanding of essential aspects…
GLP-1 receptor agonists tied to similar thyroid cancer risk as DPP-IV inhibitors
Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according…
More than 70 organizations urge the Trump administration to finalize the CMS proposed rule to extend access to obesity medications for people in Medicare and Medicaid.
We, the undersigned organiza tions, are enthusiastically supportive of the proposed rule by the Centers for Medicare & Medicaid Services (CMS) to align coverage policy…